STRM:NSD-Streamline Health Solutions Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 2.57

Change

+2.37 (+1,185.64)%

Market Cap

USD 0.01B

Volume

0.10M

Analyst Target

USD 2.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in North America. The company offers RevID, a cloud-based automated revenue reconciliation software as a service (Saas) solution that delivers automated daily charge reconciliation, which identifies discrepancies between a provider's clinical and billing departments and ensures that every medical service is tracked, accounted for, and accurately billed and reduce revenue leakage; and eValuator, a coding analysis platform that delivers the capability of fully automated analysis on billing codes entered by a healthcare provider's coding team. It also provides Data Comparison Engine, a cloud-based SaaS system synchronization module that operates and automates the reconciliation of these systems to identify discrepancies or errors occurring between systems; CDI that provides an integrated on-premise or cloud-based software suite that enhances the productivity of CDI and Coding staff and enables the seamless sharing of patient data; and Financial Management Solutions, which offers financial staff across the healthcare enterprise with actionable and real-time financial data and key performance indicators to improve revenue realization. In addition, the company provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.48 (+0.71%)

USD 10.78B
DOCS Doximity Inc

+0.46 (+1.06%)

USD 7.70B
WEAV Weave Communications Inc

+0.47 (+3.75%)

USD 0.89B
AMWL American Well Corp

+0.29 (+3.20%)

USD 0.14B
MPLN MultiPlan Corporation

+1.02 (+12.78%)

USD 0.12B
OWLT Owlet Inc

-0.07 (-1.53%)

USD 0.07B
LFMDP LifeMD Inc Preferred Series A

-0.25 (-1.12%)

N/A
PHR Phreesia Inc

+0.12 (+0.54%)

N/A
VEEV Veeva Systems Inc Class A

+0.14 (+0.07%)

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing STRM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -59.69% 25% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -59.69% 25% F 2% F
Trailing 12 Months  
Capital Gain -80.01% 25% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -80.01% 25% F 1% F
Trailing 5 Years  
Capital Gain -82.34% 40% F 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -82.34% 40% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain -4.86% N/A N/A 32% F
Dividend Return -4.86% N/A N/A 30% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 55.41% N/A N/A 32% F
Risk Adjusted Return -8.78% N/A N/A 34% F
Market Capitalization 0.01B 14% F 9% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector